Berkel, Caglar, Cacan, Ercan (2021) Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer. Life Sciences, 286. 120029pp. doi:10.1016/j.lfs.2021.120029
| Reference Type | Journal (article/letter/editorial) | ||
|---|---|---|---|
| Title | Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer | ||
| Journal | Life Sciences | ||
| Authors | Berkel, Caglar | Author | |
| Cacan, Ercan | Author | ||
| Year | 2021 (December) | Volume | 286 |
| Publisher | Elsevier BV | ||
| DOI | doi:10.1016/j.lfs.2021.120029Search in ResearchGate | ||
| Generate Citation Formats | |||
| Mindat Ref. ID | 13601211 | Long-form Identifier | mindat:1:5:13601211:7 |
| GUID | 0 | ||
| Full Reference | Berkel, Caglar, Cacan, Ercan (2021) Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer. Life Sciences, 286. 120029pp. doi:10.1016/j.lfs.2021.120029 | ||
| Plain Text | Berkel, Caglar, Cacan, Ercan (2021) Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer. Life Sciences, 286. 120029pp. doi:10.1016/j.lfs.2021.120029 | ||
| In | (2021) Life Sciences Vol. 286. Elsevier BV | ||
See Also
These are possibly similar items as determined by title/reference text matching only.
